Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and Patients.

Journal:
Cancer Research
Published:
DOI:
10.1158/0008-5472.can-25-0995
Affiliations:
6
Authors:
14
Go to article
Institutions Authors Share
Curie Institute, France
12.000000
12.000000
 0.86
University Hospital of Lausanne (CHUV), UNIL, Switzerland
1.000000
 0.07
Paris Cité University, France
1.000000
 0.07
Interested in Oncology and Carcinogenesis?